NCT06805500Completed
Robotic Assisted Balance and Exoskeleton Training (REACTION) in Neurorehabilitation: a Feasibility Study
Source: ClinicalTrials.gov · Last updated 7 May 2026
Brief summary (registry, in English)
The goal of this clinical trial is to explore the effect on walking speed of a new robotic assisted balance and gait trainer (REACTION) and their subsystems in individuals with neurological disorders. The study will provide insight in the feasibility of REACTION. Participants will: * Participate in two sessions in which every session contains a walking task and balance tasks * end the study with a semi-structured interview
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 7 (actual)
- First submitted
- 16 Jan 2025
- Start date
- 7 May 2025
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Roessingh Research and Development
- Diseases
- Stroke
- NCT number
- NCT06805500
What you commit to
- Study type: Interventional
- Participants enrolled: 7
- From 7 May 2025 to the primary completion date, 31 Dec 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Progressive neurological diseases like dementia or Parkinson
Other
- A potential participant who meets any of the following criteria will be excluded from participation in this study:
- Premorbid disability of lower extremity
- Skin lesions or severely impaired sensation at the hemiparetic leg
- Contraindication for mobilization, like lower limb fracture
- Insufficient knowledge of the Dutch language to understand the purpose or meth-ods of the study
- Pregnancy
Criteria the registry did not label
- In order to be eligible to participate in this study, a participant must meet all of the following criteria:
- Age \> 16 years
- Able to give informed consent
- Stroke patients:
- first-ever ischemic or haemorrhagic stroke
- FAC score between 3 and 4
- (Sub)acute or chronic phase
- SCI patients:
- Neurological injury levels ranging from C5 to T9
- Motor incomplete spinal cord injury (ASIA impairment score of C or D)
- Able to walk independently (without physical support)
Age in the registry: 16 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Roessingh Research and Development Coordinator of this site? Confirm its status | Enschede | Netherlands | Unknown status |
| Sint Maartenskliniek Coordinator of this site? Confirm its status | Ubbergen | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.